← Mechanisms of action
Ganglioside GD3
LIPIDHomo sapiens
Drugs acting on this target (11)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| kw2871 | Adcc | experimental | mAb | ganglioside GD3 |
| R24 | Adcc | experimental | mAb | ganglioside GD3 |
| klh-linked gd2l and gd3l | Immunity, active | experimental | Vaccine | Ganglioside GD3 immunity, active |
| kw2871 | Immunity, passive | experimental | mAb | Ganglioside GD3 immunity, passive |
| mitumomab | Immunity, passive | experimental | mAb | Ganglioside GD3 immunity, passive |
| pf-06688992 | Immunity, passive | experimental | mAb | Ganglioside GD3 immunity, passive |
| codrituzumab | Other | experimental | mAb | Ganglioside GD3 other |
| kw2871 | Other | experimental | mAb | Ganglioside GD3 other |
| mitumomab | Other | experimental | mAb | Ganglioside GD3 other |
| ro5137382 | Other | experimental | mAb | Ganglioside GD3 other |
| monosialic gangliosides | Supplementation | experimental | Small molecule | Ganglioside GD3 supplementation |